Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Albuterol Sulfate MDIs in Mild Asthma
NCT02624505Phase 3Completed
- Sponsor
- Cipla
- Start
- Dec 2015
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of salbutamol in asthma (4 arms), sponsored by Cipla. Primary endpoint: Provocative Concentration of Methacholine Causing 20% Fall in FEV1 at 1 day. Started Dec 2015; status: completed.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02624505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02624505.